G&S Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-96,339
| Closed | -$2.8M | – | 128 |
|
|
2024
Q2 | $2.8M | Sell |
96,339
-3,824
| -4% | -$111K | 1.22% | 27 |
|
|
2024
Q1 | $2.78M | Buy |
100,163
+26,891
| +37% | +$746K | 1.24% | 21 |
|
|
2023
Q4 | $2.11M | Buy |
73,272
+1,372
| +2% | +$39.5K | 1% | 41 |
|
|
2023
Q3 | $2.38M | Sell |
71,900
-247
| -0.3% | -$8.19K | 1.22% | 33 |
|
|
2023
Q2 | $2.65M | Buy |
+72,147
| New | +$2.65M | 1.27% | 25 |
|
|
2021
Q2 | – | Sell |
-29,680
| Closed | -$1.08M | – | 120 |
|
|
2021
Q1 | $1.08M | Buy |
29,680
+1,300
| +5% | +$47.1K | 0.63% | 46 |
|
|
2020
Q4 | $1.05M | Sell |
28,380
-1,174
| -4% | -$43.2K | 0.62% | 45 |
|
|
2020
Q3 | $1.03M | Buy |
29,554
+2,265
| +8% | +$78.9K | 0.74% | 42 |
|
|
2020
Q2 | $847K | Buy |
27,289
+2,011
| +8% | +$62.4K | 0.76% | 37 |
|
|
2020
Q1 | $782K | Sell |
25,278
-48
| -0.2% | -$1.49K | 1.37% | 18 |
|
|
2019
Q4 | $941K | Sell |
25,326
-210
| -0.8% | -$7.8K | 0.53% | 49 |
|
|
2019
Q3 | $871K | Sell |
25,536
-1,265
| -5% | -$43.1K | 0.51% | 45 |
|
|
2019
Q2 | $1.1M | Buy |
26,801
+448
| +2% | +$18.4K | 0.66% | 42 |
|
|
2019
Q1 | $1.06M | Buy |
26,353
+2,746
| +12% | +$111K | 0.65% | 36 |
|
|
2018
Q4 | $978K | Buy |
23,607
+2,474
| +12% | +$102K | 0.89% | 20 |
|
|
2018
Q3 | $884K | Hold |
21,133
| – | – | 0.61% | 34 |
|
|
2018
Q2 | $727K | Buy |
21,133
+4,427
| +26% | +$152K | 0.56% | 36 |
|
|
2018
Q1 | $563K | Buy |
16,706
+1,159
| +7% | +$39.1K | 0.48% | 46 |
|
|
2017
Q4 | $534K | Buy |
+15,547
| New | +$534K | 0.39% | 51 |
|